Acute myeloid leukemia (AML) is a disease primarily affecting older adults. However, not all
patients at older ages are suitable for curative treatment with intensive chemotherapy due to …

Childhood leukemia is a prevalent form of pediatric cancer, with acute lymphoblastic
leukemia (ALL) and acute myeloid leukemia (AML) being the primary manifestations. Timely …

Albumin is an important biochemical marker in palliative cancer care, used for assessment
of nutritional status, disease severity and prognosis. Our primary aim was to investigate sex …

Background The ratio of C-reactive protein to albumin (CAR) is an inflammatory marker that
has been demonstrated to be a simple and reliable prognostic factor in several solid …

Acute myeloid leukemia (AML) is a malignant hematological disorder in which aberrant
cytokine signaling and inflammation play a role in disease initiation and progression …

Serum albumin, known for its multifaceted role in health, is hypothesized to serve as a
prognostic marker for older adults, both in hospital and community settings. Nine studies …

Background In clinical hematology, diffuse large B-cell lymphoma (DLBCL) is notably
heterogeneous and varies in prognosis. Serum albumin (SA) is considered a biomarker of …

Background We evaluated clinical features and risk factors for mortality in patients with
haematological malignancies and COVID-19. Methods Retrospective, case–control (1: 3) …

Background Acute myeloid leukemia (AML) is the main type of adult leukemia, and 60-day
mortality is a vital clinical problem that doctors have to face at the begin with treatment …

Objective The role of hypoalbuminemia throughout the course of chronic periprosthetic joint
infection (PJI) remains poorly understood. This study aimed to determine the prevalence and …